Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin in Acute Myocardial Infarction
NCT03087773Phase 3Completed
- Sponsor
- Medical University of Graz
- Start
- May 2017
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of empagliflozin in acute myocardial infarction (AMI), sponsored by Medical University of Graz. Started May 2017; status: completed.
02
Drugs
empagliflozin
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT03087773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03087773.